Home

The Summary Overview Report now has an Insulin Pump banner. The new banner auto populates from documentation of Insulin pump LDA, Insulin pump implant or Insulin pump order.

To help patients better communicate with Central Scheduling about upcoming appointments, HM is enabling two-way texting through WELL Health starting Monday, Dec. 7.

Houston Methodist has received allocations of bamlanivimab, a monoclonal antibody for the treatment of mild to moderate COVID-19. This received Emergency Use Authorization (EUA) by the FDA. Patients meeting EUA criteria can be referred for ambulatory infusion by placing an Amb Referral to COVID-19 monoclonal antibody infusion (REF1001) order in Epic.

You can now view a patient’s eCheck-in status on the Multi-Provider Schedule (MPS) without leaving your workflow to look at the Department Appointment Report (DAR).

As required by the DNV, in the event of a restraint for violent/self-destructive behavior, document in Epic under the Restraints activity and complete the Face to Face assessment.